Physician profile
Barbara Herfel
NPI 1447425657
$67,237.38
in general payments reported to CMS, 2019-2025
5 companies · $1,479 in 2025
The $1,479 reported for 2025 was more than what a typical Clinical Pathology provider received nationally (typical 2025 total: $116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $22.85 · 2021: $2,222 · 2022: $15K · 2023: $18K · 2024: $31K · 2025: $1,479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,712.49 |
| Travel and Lodging | $296.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $67,159.25 | 2021-2025 | |
| Biofire Diagnostics, LLC | $22.85 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.11 | 2021 | |
| Eisai INC. | $18.48 | 2021 | |
| Merck Sharp & Dohme LLC | $14.69 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Herfel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.